Research Paper Volume 13, Issue 8 pp 12129—12142

Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis

Silencing DLGAP1-AS1 inhibited proliferation, migration and invasion in glioma cells. (A, B) CCK-8 assays showed the proliferative capacity of the glioma cell lines transfected with NC, sh-DLGAP1-AS1-1 or sh-DLGAP1-AS1-2. (C, D) Clone formation assays showed the proliferative capacity of the glioma cell lines transfected with NC, sh-DLGAP1-AS1-1 or sh-DLGAP1-AS1-2. (E, F) Transwell assays showed the migratory capacity of the glioma cell lines transfected with NC, sh-DLGAP1-AS1-1 or sh-DLGAP1-AS1-2. (G, H) Transwell assays showing the invasive capacity of the glioma cell lines transfected with NC, sh-DLGAP1-AS1-1 or sh-DLGAP1-AS1-2. *p

Figure 2. Silencing DLGAP1-AS1 inhibited proliferation, migration and invasion in glioma cells. (A, B) CCK-8 assays showed the proliferative capacity of the glioma cell lines transfected with NC, sh-DLGAP1-AS1-1 or sh-DLGAP1-AS1-2. (C, D) Clone formation assays showed the proliferative capacity of the glioma cell lines transfected with NC, sh-DLGAP1-AS1-1 or sh-DLGAP1-AS1-2. (E, F) Transwell assays showed the migratory capacity of the glioma cell lines transfected with NC, sh-DLGAP1-AS1-1 or sh-DLGAP1-AS1-2. (G, H) Transwell assays showing the invasive capacity of the glioma cell lines transfected with NC, sh-DLGAP1-AS1-1 or sh-DLGAP1-AS1-2. *p < 0.05, **p < 0.01.